21
Ago
PARTNER OPPORTUNITY ALERT
Comments
A German university found first-in-class inhibitors influencing the serine proteases associated with macular degeneration and reperfusion-ischemia. So far no inhibitors with drug-like characteristics have been available. The German university offers a license and/or research cooperation agreement.
| Reference: | TODE20180807001 |
| Country: | Germany |
| Submitted: | Aug 07 2018 |
| Updated: | Aug 15 2018 |
| View Partnering Opportunity |
